European Commission Approves Expanded Indication for Merck's KEYTRUDA® in Adult and Pediatric Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Pharmaceutical Investing
Merck Receives Priority Review From FDA for New Drug Application for HIF-2? Inhibitor Belzutifan Pharmaceutical Investing
Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 million Cannabis Investing News
Merck to Host Investor Briefing to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Pharmaceutical Investing
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV Biotech Investing
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS in Latest ICER Draft Evidence Report Biotech Investing
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization Medical Device Investing
Abbott Announces its Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants Medical Device Investing
